Cholangitis screening

Cholangitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cholangitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cholangitis screening On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cholangitis screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cholangitis screening
CDC on Cholangitis screening
Cholangitis screening in the news
Blogs on Cholangitis screening
Directions to Hospitals Treating Cholangitis
Risk calculators and risk factors for Cholangitis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farwa Haideri [2]

Overview

There are no accepted screening processes for cholangitis or cholangiocarcinoma, a cancer associated with this disease. Methods do exist to detect the early onset of both diseases.

Screening

The cancer predominantly associated with cholangitis is cholangiocarcinoma. There are no accepted screening programs for either disease. However, methods for detecting early onsets of cholangitis and cholangiocarcinoma include using biochemical markers, scanning using positron emission tomography (PET) scan or magnetic resonance imaging (MRI), and endoscopic procedures such as endosonography and endoscopic retrograde cholangiopancreatography.